Tarsus Pharmaceuticals, Inc.
Clinical trials sponsored by Tarsus Pharmaceuticals, Inc., explained in plain language.
Develops therapies for ophthalmic and dermatologic conditions.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
Could a single pill stop lyme disease before it starts?
Prevention OngoingThis study tests a new pill called TP-05 (lotilaner) to see if it can prevent Lyme disease in healthy adults who are often around ticks. The pill is already used in pets to kill ticks. Researchers will give either a low dose, high dose, or placebo to 700 volunteers and watch for …
Phase: PHASE2 • Sponsor: Tarsus Pharmaceuticals, Inc. • Aim: Prevention
Last updated Jul 11, 2026 00:00 UTC
-
New eye gel could ease rosacea symptoms
Symptom relief ENROLLING_BY_INVITATIONThis Phase 2 trial tests a gel called lotilaner for people with moderate to severe ocular rosacea, a condition causing red, irritated eyes. About 155 adults will receive either the gel or a placebo to see if it is safe and helps symptoms. The study is currently enrolling by invit…
Phase: PHASE2 • Sponsor: Tarsus Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC